GREB1: An evolutionarily conserved protein with a glycosyltransferase domain links ERα glycosylation and stability to cancer

Sci Adv. 2021 Mar 17;7(12):eabe2470. doi: 10.1126/sciadv.abe2470. Print 2021 Mar.

Abstract

What covalent modifications control the temporal ubiquitination of ERα and hence the duration of its transcriptional activity remain poorly understood. We show that GREB1, an ERα-inducible enzyme, catalyzes O-GlcNAcylation of ERα at residues T553/S554, which stabilizes ERα protein by inhibiting association with the ubiquitin ligase ZNF598. Loss of GREB1-mediated glycosylation of ERα results in reduced cellular ERα levels and insensitivity to estrogen. Higher GREB1 expression in ERα+ve breast cancer is associated with greater survival in response to tamoxifen, an ERα agonist. Mice lacking Greb1 exhibit growth and fertility defects reminiscent of phenotypes in ERα-null mice. In summary, this study identifies GREB1, a protein with an evolutionarily conserved domain related to DNA-modifying glycosyltransferases of bacteriophages and kinetoplastids, as the first inducible and the only other (apart from OGT) O-GlcNAc glycosyltransferase in mammalian cytoplasm and ERα as its first substrate.

Publication types

  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Breast Neoplasms* / genetics
  • Breast Neoplasms* / metabolism
  • Carrier Proteins / genetics
  • Estrogen Receptor alpha* / genetics
  • Estrogen Receptor alpha* / metabolism
  • Female
  • Gene Expression Regulation, Neoplastic
  • Glycosylation
  • Glycosyltransferases / genetics
  • Humans
  • Mammals / metabolism
  • Membrane Proteins / metabolism*
  • Mice
  • Neoplasm Proteins / metabolism

Substances

  • Carrier Proteins
  • Estrogen Receptor alpha
  • GREB1 protein, human
  • KIAA0575 protein, mouse
  • Membrane Proteins
  • Neoplasm Proteins
  • ZNF598 protein, human
  • Glycosyltransferases